Describes the structure of the insulin industry, a drug used to treat diabetes and Novo strategy and competitive position in the beginning in 1982. The industry is undergoing profound change and Novo have to decide how to defend and build their international position. Designed as an early event in the global strategy. The class can understand how Novo has competed internationally in the past, as far as industrial structure, and will change as the industry changes in the appropriate way by global competition. Coalit … Read more »

Describes the structure of the insulin industry, a drug used to treat diabetes and Novo strategy and competitive position in the beginning in 1982. The industry is undergoing profound change and Novo have to decide how to defend and build their international position. Designed as an early event in the global strategy. The class can understand how Novo has competed internationally in the past, as far as industrial structure, and will change as the industry changes in the appropriate way by global competition. Coalitions of alliances factor in the list of strategic alternatives.
«Hide

from
Michael E. Porter,
Michael J. Enright
Source: Harvard Business School
20 pages.
Publication Date: Apr 19, 1989. Prod #: 389148-PDF-ENG
Novo Industri HBR case solution